Effect of Lidocaine or Dexamethasone on Cancer Immune Response- the PILDI Study

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2028

Conditions

Colon Cancer

Interventions

DRUG

Lidocaine

intravenous infusion of lidocaine

DRUG

Dexamethasone

intravenous infusion of dexamethasone

DRUG

Placebo

saline solution intravenous infusion

Trial Locations (1)

Institute of Oncology Ljubljana, Ljubljana

All Listed Sponsors

lead

Institute of Oncology Ljubljana

OTHER